Nexentis Technologies Inc. (NXTS) intrinsic value & 10-year financials

Nexentis Technologies Inc. (NXTS) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.65
Market cap
$831.0K
Revenue (FY2025)
—
Revenue growth (9-yr CAGR)
-11.1%
ROIC (10-yr avg)
-6336.0%
Free cash flow (FY2025)
-$3.8M

NXTS 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$4.0M -$8.61 -$3.8M — -32.6%
FY2024 $210.0K -$5.2M -$0.89 — -2057.1% -254.5%
FY2023 $263.4K -$6.5M $1.09 — -2876.4% -586.1%
FY2022 $394.0K -$5.7M $2.17 -$5.1M -1477.1% -51932.7%
FY2021 $438.1K -$4.8M — -$4.2M -1073.5% 1166.4%
FY2020 $232.3K -$1.6M — — -580.9% 242.7%
FY2019 $175.8K -$2.0M — -$1.3M -1098.4% 486.5%
FY2018 $426.6K -$356.9K — -$509.0K -121.6% 222.0%
FY2017 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Nexentis Technologies Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Nexentis Technologies Inc. has historically struggled to out-earn its cost of capital, averaging just -67.4% ROIC.

Nexentis Technologies Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Nexentis Technologies Inc. is modeled at -11.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-12.91 per share.

NXTS stock: frequently asked questions

What is the intrinsic value of Nexentis Technologies Inc. (NXTS) stock?

Graham's formula only works with positive earnings. Nexentis Technologies Inc. reported diluted EPS of -$8.61 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Nexentis Technologies Inc. generate free cash flow?

Nexentis Technologies Inc. generated -$3.8M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 5 reported years.

What is NXTS's return on invested capital?

Average ROIC over the last 9 fiscal years was -6336.0%, and average return on equity was 307.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NXTS data come from?

From Nexentis Technologies Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks